Role of Portal and Splenic Vein Shunts and Impaired Hepatic Extraction in the Elevated Serum Bile Acids in Liver Cirrhosis-Reference-Cited by-同舟云学术

Role of Portal and Splenic Vein Shunts and Impaired Hepatic Extraction in the Elevated Serum Bile Acids in Liver Cirrhosis

Published:1984-03 Issue:3 Volume:86 Page:514-520
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Ohkubo Hideki,Okuda Kunio,Iida Shinji,Ohnishi Kunihiko,Ikawa Shiro,Makino Isao

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference15 articles.

1. Disturbances of bile acid metabolism in parenchymal liver cell disease;Vlahcevic;Clin Gastroenterol,1977

2. Pool size, synthesis, and turnover of sulfated and nonsulfated cholic acid and chenodeoxycholic acid in patients with cirrhosis of the liver;Stiel;Gastroenterology,1978

3. Determinants of serum bile acids in chronic liver disease;Pare;Gastroenterology,1981

4. Effects of portacaval shunt on serum bile acid concentration in patients with cirrhosis;Poupon;Digestion,1977

5. Influences of portacaval anastomosis on serum and biliary unsulfated bile acid composition in patients with liver cirrhosis;Angelico;Am J Dig Dis,1979

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced risk of overt hepatic encephalopathy and death after transjugular intrahepatic portosystemic shunt in patients with hepatic venovenous communications;European Journal of Radiology;2024-08

2. Useful Predictor for Exacerbation of Esophagogastric Varices after Hepatitis C Virus Eradication by Direct-Acting Antivirals;Livers;2024-07-30

3. Taurine-conjugated bile acids and their link to hepatic S1PR2 play a significant role in hepatitis C–related liver disease;Hepatology Communications;2024-07

4. FXR-FGF19 signaling in the gut–liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defence;Hepatology International;2024-02-08

5. Pathophysiological changes of the liver-muscle axis in end-stage liver disease: what is the right target?;Acta Gastro Enterologica Belgica;2022-12